Thermo Fisher Scientific Earnings Preview: Can This Streak Continue?

Thermo Fisher Scientific (NYSE:TMO) will report earnings before markets open on Wednesday, July 24th. Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.

Here is your Cheat Sheet to Thermo Fisher Scientific Earnings:

Earnings Expectations: Analysts expect earnings of $1.30 per share on revenues of $3.22 billion. Currently, the company’s P/E ratio stands at 25.92.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.33 to a profit $1.28. For the current year, the average estimate is a profit of $5.34, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Thermo Fisher Scientific has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 10,498 10,110 10,789 11,726 12,510
Diluted EPS ($) 2.29 2.01 2.53 3.46 3.21

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 3,108.10 3,085.70 3,259.30 3,191.50
Diluted EPS ($) 0.63 0.79 1.04 0.93

Past Performance:
Thermo Fisher Scientific has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]